VRCA
Verrica Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $34.19M | Price | $3.61 |
| Volume | 33.09K | Change | +2.27% |
| P/E Ratio | -0.4 | Open | $3.49 |
| Revenue | $7.6M | Prev Close | $3.53 |
| Net Income | $-76.6M | 52W Range | $3.43 - $15.35 |
| Div Yield | N/A | Target | $15.00 |
| Overall | 32 | Value | 40 |
| Quality | 39 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyVerrica Pharmaceuticals Inc. (VRCA) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.61 with a market capitalization of $34.19 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows VRCA with a volume of 33K shares. The stock opened down 1.13% from yesterday's close of $3.53. Current analyst estimates project earnings of $-0.99 per share for this year, with next year targeting $-1.94.
VRCA demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for VRCA include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 315.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 10:38 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRCA | $3.61 | +2.3% | 33.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Verrica Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW